Clinical Trial

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there is an opportunity to prevent gastritis, peptic ulcer disease, and even gastric cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-30; most recent amendment 2026-02-12.
Status change: Recruiting → Active, Not Recruiting 2026-02-12
Trial Details
NCT Number NCT07224035
Lead Sponsor University of Miami
Collaborators: Phathom Pharmaceuticals, NRG Oncology
Conditions H Pylori Infection, H Pylori Gastritis, Gastric Cancer
Enrollment 500 participants
Start Date 2022-10-15
Primary Completion 2027-11-06 (estimated)
Study Completion 2027-11-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-17